“
“Background: Currently, Meniere’s disease is predominantly diagnosed through clinical criteria. Additional standard vestibular testing, such as nystagmography, can show variable responses. In the last decade, the cervical vestibular DZNeP supplier evoked myogenic potential (VEMP) has shown to be of additive value in diagnosing Meniere’s disease. In this study, the results of the ocular VEMP (oVEMP) in response to air-conducted sound will be discussed.
Objectives:
To evaluate possible changes of the oVEMP in a large group (n = 37) of patients with Meniere’s disease.
Material and Methods: In 55 subjects without Meniere’s disease and 37 patients with Meniere’s disease, oVEMPs in response to air-conducted sound stimulation (tone-burst, 500 Hz; maximum stimulus level, 120 dB sound pressure level) were studied. Recording was performed in upgaze with surface electrodes underneath both eyes. The burden of the test was scored by all subjects on a visual analogue scale.
Results: In patients with Meniere’s disease the response rates are lower, the oVEMP amplitudes are smaller, and thresholds are higher than in subjects without Meniere’s disease. This effect is observed in both ears of patients with Meniere’s SBE-β-CD datasheet disease. The affected ear is more altered than the clinically unaffected ear.
Conclusion: The air-conducted oVEMP can be
a relevant addition to the current diagnostic workup of patients with possible Meniere’s disease. A lower response rate, smaller amplitude, and higher threshold of the oVEMP indicate the pathologic disease in this population.”
“Serum tumor markers have been shown to correlate with the clinical status of patients with advanced gastric cancer. However, the clinical significance of each tumor marker in patients with peritoneal dissemination has not been fully verified.
Four serum markers, carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, CA125, and CA72-4,
were periodically measured in 102 patients with peritoneal dissemination who received combination intravenous and intraperitoneal chemotherapy. TPCA-1 The initial values at diagnosis and after treatment were analyzed in association with clinicopathological factors, response to chemotherapy, and overall survival.
The sensitivities of CEA, CA19-9, CA125, and CA72-4 for peritoneal metastasis at the initial diagnosis were 19, 36, 46, and 45%, respectively. The CA125 level was significantly correlated with the degree of peritoneal dissemination and the existence of malignant ascites. Patients with ovarian metastasis showed significantly higher levels of CA72-4. The median survival time of patients with an elevated CA125 level was significantly shorter than that of patients with a normal CA125 level (36.7 vs. 16.6 months, p < 0.001). Multivariate analysis showed that the degree of peritoneal metastasis and an elevated CA125 level were independent prognostic factors.